File Download
  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Repressor and activator protein accelerates hepatic ischemia reperfusion injury by promoting neutrophil inflammatory response

TitleRepressor and activator protein accelerates hepatic ischemia reperfusion injury by promoting neutrophil inflammatory response
Authors
Issue Date2016
Citation
Oncotarget, 2016, v. 7 n. 19, p. 27711-27723 How to Cite?
AbstractRepressor and activator protein (Rap1) directly regulates nuclear factor-κB (NF-κB) dependent signaling, which contributes to hepatic IRI. We here intended to investigate the effect of Rap1 in hepatic ischemia reperfusion injury (IRI) and to explore the underlying mechanisms. The association of Rap1 expression with hepatic inflammatory response were investigated in both human and rat liver transplantation. The effect of Rap1 in hepatic IRI was studied in Rap1 knockout mice IRI model in vivo and primary cells in vitro. Our results showed that over expression of Rap1 was associated with severe liver graft inflammatory response, especially in living donor liver transplantation. The results were also validated in rat liver transplantation model. In mice hepatic IRI model, the knockout of Rap1 reduced hepatic damage and hepatic inflammatory response. In primary cells, the knockout of Rap1 suppressed neutrophils migration activity and adhesion in response to liver sinusoidal endothelial cells through down-regulating neutrophils F-Actin expression and CXCL2/CXCR2 pathway. In addition, the knockout of Rap1 also decreased production of pro-inflammatory cytokines/chemokines in primary neutrophils and neutrophils-induced hepatocyte damage. In conclusion, Rap1 may induce hepatic IRI through promoting neutrophils inflammatory response. Rap1 may be the potential therapeutic target of attenuating hepatic IRI.
Persistent Identifierhttp://hdl.handle.net/10722/225812
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorLI, C-
dc.contributor.authorLo, CM-
dc.contributor.authorLian, Q-
dc.contributor.authorNg, KTP-
dc.contributor.authorLiu, X-
dc.contributor.authorMa, YY-
dc.contributor.authorQI, X-
dc.contributor.authorYeung, WHO-
dc.contributor.authorTergaonkar, V-
dc.contributor.authorYang, X-
dc.contributor.authorLiu, H-
dc.contributor.authorLiu, J-
dc.contributor.authorShao, Y-
dc.contributor.authorMan, K-
dc.date.accessioned2016-05-20T08:11:10Z-
dc.date.available2016-05-20T08:11:10Z-
dc.date.issued2016-
dc.identifier.citationOncotarget, 2016, v. 7 n. 19, p. 27711-27723-
dc.identifier.urihttp://hdl.handle.net/10722/225812-
dc.description.abstractRepressor and activator protein (Rap1) directly regulates nuclear factor-κB (NF-κB) dependent signaling, which contributes to hepatic IRI. We here intended to investigate the effect of Rap1 in hepatic ischemia reperfusion injury (IRI) and to explore the underlying mechanisms. The association of Rap1 expression with hepatic inflammatory response were investigated in both human and rat liver transplantation. The effect of Rap1 in hepatic IRI was studied in Rap1 knockout mice IRI model in vivo and primary cells in vitro. Our results showed that over expression of Rap1 was associated with severe liver graft inflammatory response, especially in living donor liver transplantation. The results were also validated in rat liver transplantation model. In mice hepatic IRI model, the knockout of Rap1 reduced hepatic damage and hepatic inflammatory response. In primary cells, the knockout of Rap1 suppressed neutrophils migration activity and adhesion in response to liver sinusoidal endothelial cells through down-regulating neutrophils F-Actin expression and CXCL2/CXCR2 pathway. In addition, the knockout of Rap1 also decreased production of pro-inflammatory cytokines/chemokines in primary neutrophils and neutrophils-induced hepatocyte damage. In conclusion, Rap1 may induce hepatic IRI through promoting neutrophils inflammatory response. Rap1 may be the potential therapeutic target of attenuating hepatic IRI.-
dc.languageeng-
dc.relation.ispartofOncotarget-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.titleRepressor and activator protein accelerates hepatic ischemia reperfusion injury by promoting neutrophil inflammatory response-
dc.typeArticle-
dc.identifier.emailLo, CM: chungmlo@hkucc.hku.hk-
dc.identifier.emailLian, Q: qzlian@hkucc.hku.hk-
dc.identifier.emailLiu, X: liuxb301@hku.hk-
dc.identifier.emailYeung, WH: why21@hku.hk-
dc.identifier.emailYang, X: dryangxx@hku.hk-
dc.identifier.emailShao, Y: yshao@hku.hk-
dc.identifier.emailMan, K: kwanman@hku.hk-
dc.identifier.authorityLo, CM=rp00412-
dc.identifier.authorityLian, Q=rp00267-
dc.identifier.authorityMan, K=rp00417-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.18632/oncotarget.8509-
dc.identifier.scopuseid_2-s2.0-84968830216-
dc.identifier.hkuros258063-
dc.identifier.hkuros291598-
dc.identifier.volume7-
dc.identifier.issue19-
dc.identifier.spage27711-
dc.identifier.epage27723-
dc.identifier.isiWOS:000377741700061-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats